Optimi Health Corp. (NASDAQ:OPTH) Short Interest Down 71.2% in July

Optimi Health Corp. (NASDAQ:OPTH) saw a large drop in short interest in the month of July. As of July 31st, there was short interest totaling 20,776 shares, a drop of 71.2% from the July 15th total of 72,205 shares. Approximately 0.4% of the company’s shares are short sold. Based on an average daily trading volume, of 34,203 shares, the short-interest ratio is presently 0.6 days.

Optimi Health Price Performance

NASDAQ:OPTH opened at $4.75 on Thursday. The company has a current ratio of 0.06, a quick ratio of 0.03 and a debt-to-equity ratio of 0.04. Optimi Health has a 1-year low of $4.00 and a 1-year high of $6.40. The business has a 50-day simple moving average of $4.70. The stock has a market capitalization of $27.22 million and a price-to-earnings ratio of -13.19.

Analyst Ratings Changes

A number of brokerages recently weighed in on OPTH. Zacks Research upgraded shares of Optimi Health to a “hold” rating in a report on Thursday, May 28th. Weiss Ratings began coverage on shares of Optimi Health in a research note on Thursday, May 21st. They set a “sell (d-)” rating for the company. Finally, Wall Street Zen upgraded Optimi Health to a “hold” rating in a report on Saturday, July 25th. One investment analyst has rated the stock with a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, Optimi Health currently has a consensus rating of “Reduce”.

About Optimi Health

Optimi Health Corp. is a commercial-stage pharmaceutical company focused on manufacturing and distributing GMP-grade psychedelic drug products for mental health therapies. Optimi Health Corp. is based in VANCOUVER, BC.